Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation

Summary

Study includes 5 visits, when all basic clinical information, vital signs, symptoms, and side effects are going to be assessed at each appointment. Patients are going to be assigned by the computer, to receive an active or non-active drug for 14 days in a first phase. The order will be change during the second phase. The 2 weeks break without our medication will separate these phases. A very close observation regarding safety of our subjects will be implemented by study personnel and clinical investigators.

Timeline

Start

2015-09-01

Primary completion

2026-10

Completion

2027-01

Drugs

Indications